Neuroimaging at 3T vs 7T: Is It Really Worth It?

Stephen E. Jones, Jonathan Lee, Meng Law

Research output: Contribution to journalReview ArticleResearchpeer-review

8 Citations (Scopus)


Food and Drug Administration approval of 7T MR imaging allows ultrahigh-field neuroimaging to extend from the research realm into the clinical realm. Increased signal is clinically advantageous for smaller voxels and thereby high spatial resolution imaging, with additional advantages of increased tissue contrast. Susceptibility, time-of-flight signal, and blood oxygen level–dependent signal also have favorable clinical benefit from 7T. This article provides a survey of clinical cases showcasing some advantages of 7T.

Original languageEnglish
Pages (from-to)1-12
Number of pages12
JournalMagnetic Resonance Imaging Clinics of North America
Issue number1
Publication statusPublished - Feb 2021


  • 7T
  • Brain
  • Neuroimaging
  • Ultrahigh-field (UHF) MR imaging

Cite this